8-KThe WireRoutine
Reg FD Disclosure
Filed Apr 7, 2025 · 1y ago · Accession 0000950170-25-051576
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Acrivon Therapeutics, Inc.
- Ticker
- ACRV
- CIK
- 1781174
- Form type
- 8-K
- Filing date
- Apr 7, 2025
- Report date
- Apr 7, 2025
- Document
- acrv-20250407.htm
- Size
- 266 KB